Regeneration enhancer-mediated control of FGF8 expression promotes mouse fingertip regeneration

Background: A gene delivery strategy investigated in mouse fingertips
In a mouse fingertip regeneration model, regulating FGF8 expression with a regeneration enhancer partly rescued regeneration defects caused by gene deletion and accelerated regeneration in wild-type mice. Published in PNAS, this preclinical study explored regeneration-related factors shared across animal species and connected those findings to gene delivery experiments. The study used mouse fingertips as a model of partial limb regeneration in mammals; its findings should not be interpreted as evidence of whole-finger regeneration.
To activate the body's regeneration program after limb loss, researchers need to determine which molecules to express and where. Suitable delivery system configurations and molecular targets for repairing the appendicular skeleton remain insufficiently established. The researchers sought clues in gene expression in animals with high regenerative capacity.
Key findings: SP transcription factor function and the effects of FGF8 delivery
The researchers analyzed single-cell RNA sequencing data from zebrafish caudal fin regeneration alongside gene expression data collected during salamander limb and mouse fingertip regeneration. The analysis identified epidermally expressed SP-family transcription factors as candidates potentially involved in appendage regeneration across species. Transcription factors are proteins that regulate gene expression.
Gene deletion experiments confirmed the function of these factors. Loss of Sp8 in salamanders impaired limb regeneration. In mice, conditional deletion of Sp6, Sp8, or both genes in the basal epidermis caused defects in fingertip bone regeneration. The mouse regeneration defects reportedly involved an interleukin-17 (IL-17)-mediated osteoclast formation program. However, the available abstract alone does not allow assessment of the detailed causal pathways or the effect size under each deletion condition.
Next, the researchers regulated the expression of fibroblast growth factor 8 (FGF8), a known target of SP transcription factors. They used a zebrafish-derived tissue regeneration enhancer and an adeno-associated virus (AAV) vector to focus FGF8 expression in time and space. Here, an enhancer is a DNA element that regulates gene expression and is distinct from an SP transcription factor protein.
With this strategy, fingertip regeneration was partially restored in SP-deficient mice and accelerated in wild-type mice. These two outcomes—alleviation of a deletion-related regeneration defect and promotion of regeneration in wild-type animals—should be distinguished. The abstract does not provide specific figures for regeneration speed or the extent of recovery, the administered dose, or the observation period.
Significance and outlook: Connecting regeneration factor discovery to expression control
The study used deletion experiments to validate the function of SP transcription factors identified through cross-species expression comparisons, then linked regulation of their target FGF8 to regeneration outcomes in mouse fingertips. It illustrates a move beyond identifying molecules involved in regeneration to testing a delivery strategy that considers both the timing and location of expression. Follow-up studies could use this configuration to assess quantitative regeneration effects, functional recovery, and the durability and safety of expression control.
The outcomes established so far are partial restoration and acceleration of fingertip regeneration in animal models. The available abstract does not confirm complete restoration of multiple tissues or recovery of sensory nerve function, nor does it allow assessment of efficacy and safety in humans. Further validation would be needed to translate these findings into a treatment for human finger regeneration.
The study coverage is based on the provided Europe PMC bibliographic record and abstract for the PNAS paper.
Proceedings of the National Academy of Sciences, Volume 123, Issue 17, April 2026. Significance Instructing regeneration of complex structures in mammals remains an unsolved problem. Gene therapy offers a compelling approach to foster endogenous regeneration by delivering therapeutic gene products to specific cells postinjury. We ...
For researchers designing regenerative therapies, this study connects candidate factor discovery with gene delivery experiments. Its significance lies in confirming, through deletion experiments, the function of SP transcription factors identified during regeneration across species and regulating expression of their target FGF8 with a regeneration enhancer. Follow-up animal studies could use this configuration to assess the amount and speed of fingertip bone regeneration, as well as functional recovery, under different delivery conditions. Partial rescue in SP-deficient mice and accelerated regeneration in wild-type mice should be treated as distinct outcomes. Because the abstract does not establish efficacy or safety in humans, the work is best used as a preclinical design rationale for regulating the expression of regeneration signals, rather than as evidence of clinical treatment outcomes.